Recognised by Who’s Who Legal as the leading international law firm for Life Sciences since 2007, our International Life Sciences Group works with over 50 % of the world’s largest pharmaceutical companies and has the largest patent litigation group in Europe.
Our practice is built on the belief that it is important to understand the scientific, ethical and business challenges facing companies in the sector to provide practical and commercially viable advice for our clients.
Our lawyers can advise on every aspect of the business cycle of a life science product or service. They can help you with corporate, regulatory, licensing and commercial transactions, competition & EU law and intellectual property advice. Specifically including technology transfers, IP licensing and transactions, regulatory and privacy issues, competition law, R&D collaborations, clinical trials, marketing arrangements, trade mark and patent disputes and product liability.
We work with a vast array of companies from pharmaceutical, bioinformatics, medical devices, biotech companies, universities and university spin outs, to investors and venture capital companies, manufacturers, distributors and clinical research organisations. We take a multi-disciplinary approach, delivering more than just the core legal and litigation services.
Heads of Group: Marc Martens in Brussels and Mark Hilton in London.
Chambers UK 2016
Chambers Asia Pacific, 2015
Chambers UK 2015
Chambers Global 2014
Chambers Global 2016
Since liberalisation at the beginning of 2017, industrial and medical Cannabis have experienced a boom in Germany.
Each Belgian biobank will have to be declared at the Federal Agency for Medicines and Health Products (FAMHP) in order to operate. It also imposes binding content for agreements on the transfer of human biological ...
Last month, the Belgian Parliament voted in favour of a set of measures that are notably meant to clarify the regulatory landscape of the operators active in the manufacturing of Advanced Therapy Medicinal Products ...
There are no forthcoming events for this area. Please click on the button below to view past events.
Australia's new Therapeutic Goods Advertising Code effective 1 January 2019: https://t.co/QAhNnqkMVU
RT @LSXLeaders: Download the brochure to see who's already coming to the LSX World Congress 2019: https://t.co/8AVOjj1jnw #LSXWORLD https:/…
RT @LifeSciencesIPR: ' A Perspective on Recent UK Supreme Court Caselaw': Chris de Mauny, Associate, Barrister, Bird & Bird takes us throug…